Skip to content
<title>Channels - Teclistamab for Relapsed or Refractory Multiple Myeloma: A Review of Efficacy, Safety, Resistance Mechanisms and Future Directions :: FRELIP Discovery
Channels Teclistamab for Relapsed or Refractory Multiple Myeloma: A Review of Efficacy, Safety, Resistance Mechanisms and Future Directions
The Role of Genomics in the Development and Treatment of Multiple Myeloma: Understanding the Challenges and Opportunities
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review
Surface Micro‐Discharge Plasma for Multiple Teeth Bleaching: Efficacy, Mechanism and Safety
Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST Study
Retracted: Continuous Renal Replacement Therapy for Hypertension Complicated by Refractory Heart Failure: An Analysis of Safety and Nursing Highlights
Long-term efficacy of endoscopic radiofrequency Stretta therapy for patients with refractory ...
Cost‐Effectiveness of Dimethyl Fumarate Versus Teriflunomide in Patients With Relapsing‐Remitting Multiple Sclerosis (RRMS) in Iran
Organoids: technology refining, current applications and future directions
Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy
Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Review
Research on the Role of Autophagy in Vascular Endothelial Cells in the Healing of Chronic Refractory Wounds
Desiderata for a biomedical knowledge network: opportunities, challenges and future directions
Beyond Monotherapy: Exploring the Efficacy and Safety of Dual Biologic Strategies in Rheumatic Diseases
Acquired resistance in Stenotrophomonas maltophilia: Mechanisms underlying the shift from multidrug to pandrug resistance
Harnessing artificial intelligence for genomic variant prediction: advances, challenges, and future directions
Outcome and safety of single-dose docetaxel–augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience
Advances in Eco‐Friendly Extraction of Fruit Bioactive Compounds: Technologies, Challenges and Future Directions
Transforming telemedicine through predictive, preventive, and personalized medicine (PPPM): innovations, challenges, and future directions
Dual Blocking of IL17A and IL36R for the Treatment of Refractory Hidradenitis Suppurativa: A Case Report
Colistin Resistance in Bacteria: Current Updates on Mechanism of Action and Combating Strategies
Epigenetic modifications in cancer drug resistance: molecular mechanisms and therapeutic interventions
Streamlining safety assessments for genome-edited crops: lessons from powdery mildew-resistant wheat in China
Molecular Mechanism Underlying Resistance Variation to the Novel Agrochemical Quinofumelin in Fusarium graminearum
A robust low-friction triple network hydrogel based on multiple synergistic enhancement mechanisms
